First Time Loading...

Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 1.8 CAD Market Closed
Updated: Apr 29, 2024

Theratechnologies Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theratechnologies Inc
Revenue Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Theratechnologies Inc
TSX:TH
Revenue
$78.1m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
27%
Zymeworks Inc
NYSE:ZYME
Revenue
$76m
CAGR 3-Years
25%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Revenue
$51.1m
CAGR 3-Years
700%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Revenue
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Revenue
$175.5m
CAGR 3-Years
52%
CAGR 5-Years
223%
CAGR 10-Years
68%
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%

See Also

What is Theratechnologies Inc's Revenue?
Revenue
78.1m USD

Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Revenue amounts to 78.1m USD.

What is Theratechnologies Inc's Revenue growth rate?
Revenue CAGR 10Y
27%

Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Theratechnologies Inc have been 6% over the past three years , 8% over the past five years , and 27% over the past ten years .